We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lidco Group Plc | LSE:LID | London | Ordinary Share | GB0030546849 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.75 | 11.50 | 12.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/8/2017 20:11 | Myosite Results from a 127 patients, single-centre, patient-blinded, randomised controlled trial for elective colorectal surgery within an enhanced recovery programme, were presented on 6th July 2016 at ACPGBI. Patients received simultaneous monitoring using oesphageal Doppler (ODM) and LiDCOrapid when undergoing both open and laparoscopic surgery. The authors concluded: “Marked disagreement was observed in GDFT guided by LiDCOrapid versus ODM in colorectal ERP patients. Length of stay may be prolonged in the LiDCOrapid group”. | doglover2003 | |
07/8/2017 18:12 | doglover which journal was that RCT published in? | myosite | |
07/8/2017 11:07 | Hi Listen to this morning's interview with Matt Sassone, share it where you can. | 7767 | |
06/8/2017 19:09 | buywell3 (5185): The authors concluded: “Marked disagreement was observed in GDFT guided by LiDCOrapid versus ODM in colorectal ERP patients. Length of stay may be prolonged in the LiDCOrapid group”. I hate to jump to conclusions, but that does rather suggest that ODM is better. | arf dysg | |
06/8/2017 16:13 | Which means what it says The length of stay MAY be prolonged in the LiDCOrapid group Then again it MAY not The MAIN thing is , lest we forget The NHS are buying more and more LiDCO Monitors and Less and Less DEMG Monitors and as it happens less Maquet and EdwardsLifescience monitors also. Now ask yourselves why is the NHS doing that .... year after year Could it be that the NHS Clinicians and doctors MAY think that the LiDCO technology works better ? LiDCO IMO will have 60% of the Hemodynamic Monitoring NHS market next year , they have over 50% now There new LiDCOunity v2 monitor has just been released and should be selling well into the NHS as of now Being positive about ones investment choice is beneficial to ones health I find Being negative as ones investment plummets must be terrible I would imagine | buywell3 | |
06/8/2017 16:09 | Conclusion The authors concluded: “Marked disagreement was observed in GDFT guided by LiDCOrapid versus ODM in colorectal ERP patients. Length of stay may be prolonged in the LiDCOrapid group”. | buywell3 | |
06/8/2017 12:49 | Lest we forget: St Thomas’ RCT, July 2016 Summary Length of Stay significantly shorter in ODM patients (6 vs. 8 days; p=0.01). Compared to ODM, LiDCOrapid has poor sensitivity and wide limits of agreement Significantly more LiDCOrapid patients treated with vasopressors (56% vs. 33%, p=0.01). ODM patients mobilised one day before LiDCOrapid ones (p=0.038). ODM and LiDCOrapid are not interchangeable. | doglover2003 | |
04/8/2017 09:50 | Buywell3, that chart makes very interesting reading. | willib2 | |
04/8/2017 09:42 | Never kick a man when he's down Their demise will however add to LID sales | buywell3 | |
04/8/2017 08:39 | Reality sinking in over on the doomedtex bb | trentendboy | |
04/8/2017 06:55 | I posted some time ago re LiDCO now being on the NHS Supply Chain List They managed at long last to get on this list around August 2016 At the time of my posting they had 2 products on the list They now have 3 See Page 9 Maquet you will note have 1 (now owned by Getinge ) | buywell3 | |
28/7/2017 21:14 | C23u I should dyor - ELS is a US company | myosite | |
28/7/2017 18:30 | myosite Sorry; as you have by now ascertained I am somewhat prolific in the posting dept. The last couple of days my thoughts have been elsewhere with some interesting developments which I don't want to clutter this thread with. But they are there in the ether for you to catch at your leisure I need to take a break for a couple of days ... I assure you the post is nearly done I will try to get it out by the end of next week I am sure you know when you start researching something ... one thing leads you somewhere else and so on ... sometimes in 2 directions at once But I like finding things out ... my mate Mr Google makes it easy if you know how to ask him nicely LiDCO is going well I am sure , thus as I have done twice today ... and that has not happened for over 1 year ''buywell3 wishes to make it known that LiDCO has received the buywell3 seal of approval'' Not given lightly and difficult to get dyor | buywell3 | |
28/7/2017 18:13 | Why on earth would Veolia want to buy Edwards Lifesciences? | mrc2u | |
28/7/2017 17:38 | Buywell3 I've read your other posts thx for the investment advice. who will by Lid from your research? - I know that Veolia might be interested in its UK competitor by q4 | myosite | |
27/7/2017 13:01 | My missus says that too when I come out of the shower I don't burn millions of brain cells writing these effing long posts for nothing Take a look and get reading | buywell3 | |
27/7/2017 09:08 | I like the cut of your jib Buywell LOL | trentendboy | |
27/7/2017 08:07 | Funny that Feb has you on filter buywell.Sticking ones head in sand is a poor investment strategy. | trentendboy | |
26/7/2017 23:11 | A nurdle, I believe. Sad | mrc2u | |
26/7/2017 22:56 | Mornington crescent | myosite | |
26/7/2017 22:54 | Prefer Ealing and Earlsfield | mrc2u | |
26/7/2017 22:40 | what about you MrC? | myosite | |
26/7/2017 22:36 | Arf, thank u for both those points. | willib2 | |
26/7/2017 21:22 | MSAs in Dulwich or Deptford?You aren't allowed to miss out letters you know | mrc2u |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions